The contract development and manufacturing company will deploy the funds infused by Piramal Alternatives for improving its infrastructure and capacities, technology upgrade and a nutraceuticals manufacturing facility, as per an official statement.
Piramal Group arm invests Rs 110 crore in Biodeal Pharma
